HypGen Inc. (HPGN) financial statements (2020 and earlier)

Company profile

Business Address 1999 AVENUE OF THE STARS
CENTURY CITY, CA 90067
State of Incorp. NV
Fiscal Year End May 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

5/31/2018
5/31/2017
5/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 80
Cash and cash equivalents 80
Prepaid expense 2 
Disposal group, including discontinued operation 12 
Total current assets: 220
Noncurrent Assets
Property, plant and equipment1 14
Total noncurrent assets:1 14
Other undisclosed assets  (1)
TOTAL ASSETS:12213
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3115 
Accrued liabilities 11 
Employee-related liabilities185  
Interest and dividends payable474 
Other undisclosed accounts payable and accrued liabilities(201)  
Debt45  
Due to related parties  1
Other undisclosed current liabilities267  
Total current liabilities:343151
Noncurrent Liabilities
Liabilities, other than long-term debt400200 
Due to related parties400200 
Total noncurrent liabilities:400200 
Total liabilities:7432151
Stockholders' equity
Stockholders' equity attributable to parent(742)(193)12
Preferred stock2  
Common stock13655
Additional paid in capital2503939
Accumulated deficit(1,129)(237)(32)
Total stockholders' equity:(742)(193)12
TOTAL LIABILITIES AND EQUITY:12213

Income statement (P&L) ($ in thousands)

5/31/2018
5/31/2017
5/31/2016
Revenues  133
Cost of revenue
(Cost of Goods and Services Sold)
  (125)
Gross profit:  7
Operating expenses(639)(218)(53)
Operating loss:(639)(218)(46)
Nonoperating income2423 
Interest and debt expense(30)(4) 
Loss from continuing operations before equity method investments, income taxes:(427)(219)(46)
Other undisclosed loss from continuing operations before income taxes(465)  
Net loss:(892)(219)(46)
Other undisclosed net income (loss) attributable to parent 14(0)
Net loss available to common stockholders, diluted:(892)(205)(46)

Comprehensive Income ($ in thousands)

5/31/2018
5/31/2017
5/31/2016
Net loss:(892)(219)(46)
Comprehensive loss, net of tax, attributable to parent:(892)(219)(46)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: